In­ter­galac­tic Ther­a­peu­tics, a non-vi­ral gene ther­a­py biotech, lays off all em­ploy­ees

Non-vi­ral gene ther­a­py mak­er In­ter­galac­tic Ther­a­peu­tics has laid off all work­ers, ac­cord­ing to an em­ploy­ee’s post on LinkedIn, just weeks af­ter the biotech said it would start clin­i­cal tri­als next year for cer­tain con­di­tions that lead to blind­ness.

The Cam­bridge, MA-based biotech now seeks a buy­er, the Boston Busi­ness Jour­nal re­port­ed Tues­day af­ter­noon. On June 27, In­ter­galac­tic had said it would bring its gene ther­a­py IG-002 in­to Phase I stud­ies next year based on da­ta from a non-hu­man pri­mate study.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER